News Channels

15 Aug 2017 Publication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors
15 Aug 2017 Takeda Announces Alliance with Stanford University to Drive Therapeutic Discoveries
15 Aug 2017 ONC201 Trial for Neuroendocrine Cancer Begins at Cleveland Clinic
15 Aug 2017 Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.
15 Aug 2017 Saniona AB: Saniona's partner, Luc Therapeutics, nominates clinical candidate and initiates preclinical development in joint Ataxia program
15 Aug 2017 Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee
15 Aug 2017 Zynerba Pharmaceuticals Announces that Results from Phase 2 STOP Trial Support Continued Development of ZYN002 in Osteoarthritis
15 Aug 2017 Conatus Announces Completion of Enrollment in ENCORE-NF Phase 2b Clinical Trial of Emricasan in Patients with NASH Fibrosis
15 Aug 2017 Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
15 Aug 2017 U.S. FDA Removes Clinical Hold on CEL-SCI’s Phase 3 Head & Neck Cancer Trial
15 Aug 2017 Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola™ (apaziquone) in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)
15 Aug 2017 HitGen and Aduro Enter Research Collaboration
14 Aug 2017 Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus
12 Aug 2017 Achieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation Treatment
12 Aug 2017 Gilead Announces U.S. FDA Priority Review Designation for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV
12 Aug 2017 Phase 2b Results of Viamet’s Oral VT-1161 for the Treatment of Recurrent Vulvovaginal Candidiasis Presented at IDSOG Annual Meeting
12 Aug 2017 Ionis to Independently Advance Inotersen and IONIS-FB-L Rx
11 Aug 2017 Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
11 Aug 2017 KemPharm Announces Preliminary Results from KP415 Pharmacokinetic Single and Multiple Dose Trial
11 Aug 2017 Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected Checkpoint Fusion Proteins in Immuno-Oncology

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top